文献速递心力衰竭与心肌病

电子警报改善门诊心衰治疗:一项集群随机试验

Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
PubMed 文献 · J Am Coll Cardiol · 2022-04-03

PROMPT-HF 是一项基于电子健康记录的实用集群随机试验,将 100 名照护 HFrEF 患者的提供者随机分入警报组或常规照护组,共纳入 1310 名门诊患者。30 天时警报组 GDMT 类别处方增加率显著高于常规组(26% vs 19%,调整相对风险 1.41,95%CI 1.03-1.93,P=0.03),需警报 14 例可增加一例 GDMT 类别处方。

要点

  • 实时、个体化 EHR 警报可显著提高 HFrEF 门诊患者 30 天 GDMT 处方率。
  • 警报组主要结局发生率 26%,常规组 19%,调整相对风险 1.41(95%CI 1.03-1.93,P=0.03)。
  • 需警报 14 例患者才能增加一例 GDMT 类别处方,79% 被警报提供者认为警报有效。

核心结论

  • 针对 HFrEF 门诊患者的实时、靶向、个体化 EHR 警报系统较常规照护显著提高 30 天 GDMT 处方率。
  • 该低成本干预可快速整合入临床照护,加速心衰高价值疗法的采纳。

研究设计与样本

  • PROMPT-HF 为实用、基于 EHR 的集群随机比较效果试验,100 名照护 HFrEF 患者的提供者随机分入警报组或常规照护组。
  • 2021 年 4 月至 10 月共纳入 1310 名门诊 HFrEF 患者,中位年龄 72 岁,31% 女性,18% 黑人,中位左室射血分数 32%。

主要发现

  • 基线时 84% 使用 β 受体阻滞剂,71% 使用肾素-血管紧张素-醛固酮系统抑制剂,29% 使用盐皮质激素受体拮抗剂,11% 使用钠-葡萄糖协同转运蛋白-2 抑制剂。
  • 主要结局在警报组 685 例中发生 176 例(26%),常规组 625 例中发生 117 例(19%),警报暴露后 GDMT 类别处方增加 >40%(调整相对风险 1.41;95%CI 1.03-1.93;P=0.03)。
  • 需警报 14 例患者才能增加一例 GDMT 类别处方;79% 被警报提供者同意警报有效改善心衰药物治疗处方。

关键数值与推荐

  • 主要结局为随机化后 30 天处方 GDMT 类别数量的增加。
  • 警报向提供者通知个体化 GDMT 推荐及患者特征。

临床怎么用

  • 可在门诊 HFrEF 患者中整合实时、靶向、个体化 EHR 警报,以促进 GDMT 处方。
  • 该干预低成本,可快速融入临床照护并加速高价值疗法采纳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of guideline-directed medical therapy (GDMT) is underprescribed in patients with heart failure with reduced ejection fraction (HFrEF). OBJECTIVES: This study sought to examine whether targeted and tailored electronic health record (EHR) alerts recommending GDMT in eligible patients with HFrEF improves GDMT use. METHODS: PROMPT-HF (PRagmatic trial Of Messaging to Providers about Treatment of Heart Failure) was a pragmatic, EHR-based, cluster-randomized comparative effectiveness trial. A total of 100 providers caring for patients with HFrEF were randomized to either an alert or usual care. The alert notified providers of individualized GDMT recommendations along with patient characteristics. The primary outcome was an increase in the number of GDMT classes prescribed at 30 days postrandomization. Providers were surveyed on knowledge of guidelines and user experience. RESULTS: The study enrolled 1,310 ambulatory patients with HFrEF from April to October 2021. Median age was 72 years; 31% were female; 18% were Black; and median left ventricular ejection fraction was 32%. At baseline, 84% of participants were receiving β-blockers, 71% received a renin-angiotensin-aldosterone system inhibitor, 29% received a mineralocorticoid receptor antagonist, and 11% received a sodium-glucose cotransporter-2 inhibitor. The primary outcome occurred in 176 of 685 (26%) participants in the alert arm vs 117 of 625 (19%) in the usual care arm, thus increasing GDMT class prescription by >40% after alert exposure (adjusted relative risk: 1.41; 95% CI: 1.03-1.93; P = 0.03). The number of patients needed to alert to result in an increase in addition of GDMT classes was 14. A total of 79% of alerted providers agreed that the alert was effective at enabling improved prescription of medical therapy for HF. CONCLUSIONS: A real-time, targeted, and tailored EHR-based alerting system for outpatients with HFrEF led to significantly higher rates of GDMT at 30 days when compared with usual care. This low-cost intervention can be rapidly integrated into clinical care and accelerate adoption of high-value therapies in heart failure. (PRagmatic trial Of Messaging to Providers about Treatment of Heart Failure [PROMPT-HF; NCT04514458]).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ghazi, Yamamoto, Riello, et al. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial. J Am Coll Cardiol. 2022. PMID: 35385798. doi:10.1016/j.jacc.2022.03.338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。